Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | A161V |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | TP53 A161V lies within the DNA-binding domain of the Tp53 protein (PMID: 21232794). A161V does not result in decreased drug-induced apoptosis compared to wild-type Tp53 (PMID: 12726864), and results in interaction with Tbk1 and decreased Tbk1 and Irf3 phosphorylation and loss of Irf3 activation in culture (PMID: 33545063), but has not been fully biochemically characterized and therefore, its effect on Tp53 protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon5 TP53 A161V |
Transcript | NM_000546.6 |
gDNA | chr17:g.7675130G>A |
cDNA | c.482C>T |
Protein | p.A161V |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126112 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7675130G>A | c.482C>T | p.A161V | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|